The combined effect of Liraglutide and Sleeve Gastrectomy on Metabolic, Cardiac, Neurological and Sleep Function in Obese Individuals with Type 2 Diabetes Mellitus: A Twelve-Month, Randomised, Parallel-Group, Placebo-Controlled Study.
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 14 Aug 2018
Price : $35 *
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Registrational; Therapeutic Use
- Acronyms LIRASLEEVE
- 02 Aug 2018 Actual date last participant enrolled in this trial was 3/21/2018
- 02 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 27 Aug 2014 Status changed from not yet recruiting to recruiting, as per Australian New Zealand Clinical Trials Registry record.